"I'd been on ibuprofen for fifteen years. My gastroenterologist told me my stomach lining looked like a war zone. I needed something different. CBD gave me enough relief that I could cut my NSAID use in half — and my stomach has been much better since."
— Margaret T., 68, retired teacher, Tucson, Arizona
Margaret was diagnosed with rheumatoid arthritis at 53, though she'd had symptoms for years before — the morning stiffness that took an hour to work through, the swollen knuckles that made grading papers painful, the fatigue that she'd attributed to getting older. The diagnosis, when it finally came, was almost a relief. At least it had a name.
Her rheumatologist started her on methotrexate and a biologic medication, which controlled the disease activity reasonably well. But the residual pain and stiffness — particularly in her hands, wrists, and knees — persisted. She managed it with ibuprofen, sometimes 2,400mg daily on bad days.
"My rheumatologist kept telling me to reduce the NSAIDs. My gastroenterologist was more emphatic — he said if I kept going at that rate, I'd need a procedure. But when I cut back on the ibuprofen, the pain came back. I felt trapped."
Margaret's daughter, a physical therapist, had been following the research on CBD for musculoskeletal pain. She sent her mother several studies — including a 2016 preclinical study showing that topical CBD gel significantly reduced joint swelling and pain in arthritic rats, and a 2019 survey of arthritis patients finding that 79% reported CBD helped with pain.
"I was skeptical. I'm a retired science teacher. I wanted to see real evidence, not just testimonials." She brought the research to her rheumatologist, who was familiar with the emerging literature. "She said the evidence was preliminary but the safety profile was good, and given my NSAID situation, it was worth trying. She suggested starting with topical CBD for the hands and wrists."
Margaret began with a 500mg CBD topical cream, applied to her hands, wrists, and knees three times daily. "The first week, I wasn't sure if I was imagining it. But by week two, my morning stiffness was noticeably shorter. Instead of an hour to work through it, it was more like 30–40 minutes."
The topical approach was important for Margaret because it minimized systemic exposure — and therefore drug interaction risk with her methotrexate and biologic. Topical CBD has minimal systemic absorption, making it the safest option for patients on complex medication regimens.
After six weeks of topical use, she added an oral CBD tincture — 25mg twice daily — for more systemic anti-inflammatory effects. She worked with her rheumatologist to monitor her inflammatory markers (CRP, ESR) and watch for any interactions with her existing medications.
Over four months, Margaret gradually reduced her ibuprofen use. "I didn't do it all at once. I'd have a good week and take 400mg less. Then another good week and reduce again." By month four, she was taking 800–1,200mg ibuprofen daily on most days — down from 2,400mg — and using it only when needed rather than prophylactically.
Her gastroenterologist, at her annual endoscopy, noted improvement in her gastric mucosa. "He said it looked better than it had in years. That was the moment I knew the CBD was making a real difference — not just in how I felt, but in measurable ways."
Margaret describes the changes in practical terms: "I can open jars again. I can type for an hour without stopping. I went back to knitting, which I'd given up three years ago. These aren't dramatic things, but they're my life."
She's careful to note what CBD hasn't done: "It hasn't cured my arthritis. I still have bad days. I still take my methotrexate and my biologic — those are controlling the disease. The CBD is managing the residual pain and inflammation that the disease-modifying drugs don't fully address."
Margaret now participates in an online arthritis support community and frequently discusses her experience. Her consistent advice:
Margaret's experience aligns with emerging evidence. The Arthritis Foundation's 2019 survey found that 29% of arthritis patients reported current CBD use, with 55% reporting improvement in physical function and 67% reporting improved sleep. A 2016 study by Hammell et al. found topical CBD gel significantly reduced joint swelling, limb posture scores, and inflammatory markers in a rat model of arthritis. Human clinical trials are underway. The anti-inflammatory mechanism involves CB2 receptor activation in synovial tissue and inhibition of pro-inflammatory cytokines including TNF-α and IL-6. The Arthritis Foundation has called for more research and issued guidance supporting patient discussions with physicians about CBD use.